Hydration Pharmaceuticals

(ASX) HPC

Current Price$0.00

Market Cap$1.29M

Since IPO (2021)-99%

5 YearN/A

1 Year-73%

1 Month-25%

Hydration Pharmaceuticals Financials at a Glance

Market Cap

$1.29M

Revenue (TTM)

$5.69M

Net Income (TTM)

$219.48K

EPS (TTM)

$-0.01

P/E Ratio

-0.26

Dividend

$0.00

Beta (Volatility)

-0.37 (Low)

Dividend

$0.00

Beta (Volatility)

-0.37 (Low)

Price

$0.00

Volume

953,220

Open

$0.00

Price

$0.00

Volume

953,220

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Dividend

$0.00

Beta (Volatility)

-0.37 (Low)

Price

$0.00

Volume

953,220

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

HPC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hydration Pharmaceuticals

Industry

Personal Products

Sector

Consumer Staples

CEO

Oliver Baker

Headquarters

Melbourne, CA 92121, US

HPC Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-3.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.29M

Shares Outstanding

430.80M

Volume

953.22K

Avg. Volume

120.61K

Financials (TTM)

Gross Profit

$27.42K

Operating Income

$3.26M

EBITDA

$3.26M

Operating Cash Flow

$3.78M

Capital Expenditure

$0.00

Free Cash Flow

$3.78M

Cash & ST Invst.

$1.12M

Total Debt

$0.00

Hydration Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$963.51K

-79.7%

Gross Profit

$64.67K

-97.7%

Gross Margin

6.71%

N/A

Market Cap

$1.29M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.45M

+68.3%

EBITDA

$1.51M

-83.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.12M

+154.5%

Accounts Receivable

$80.11K

-95.4%

Inventory

$874.52K

-63.4%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

N/A

Return on Assets

-1.32%

N/A

Return on Invested Capital

-2.24%

N/A

Free Cash Flow

$2.14M

+24.2%

Operating Cash Flow

$2.14M

+24.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TFL.AXTasFoods Limited

TFL.AXTasFoods Limited$0.01+0.00%

AN1.AXAnagenics Limited

AN1.AXAnagenics Limited$0.01+0.00%

PFT.AXPure Foods Tasmania Limited

PFT.AXPure Foods Tasmania Limited$0.03+0.00%

ERG.AXEneco Refresh Limited

ERG.AXEneco Refresh Limited$0.02+0.00%

8IH.AX8I Holdings Limited

8IH.AX8I Holdings Limited$0.01+0.00%

PTL.AXPrestal Holdings Limited

PTL.AXPrestal Holdings Limited$0.03+0.00%

EVE.AXEVE Health Group Limited

EVE.AXEVE Health Group Limited$0.03-3.45%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.48+2.67%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.21+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.74+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.65+0.03%

PNSkycorp Solar Group

PNSkycorp Solar Group$5.53+0.93%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.09-0.09%

ADTADT

ADTADT$7.08-0.06%

Questions About HPC

What is the current price of Hydration Pharmaceuticals?

Hydration Pharmaceuticals is trading at A$0.00 per share.

What is the 52-week range for Hydration Pharmaceuticals?

Over the past 52 weeks, Hydration Pharmaceuticals has traded between A$0.00 and A$0.02.

How much debt does Hydration Pharmaceuticals have?

As of the most recent reporting period, Hydration Pharmaceuticals reported total debt of N/A.

How much cash does Hydration Pharmaceuticals have on hand?

Hydration Pharmaceuticals reported $1.68M in cash and cash equivalents in its most recent financial results.

What is Hydration Pharmaceuticals’s dividend yield?

Hydration Pharmaceuticals does not currently have a dividend yield.

Hydration Pharmaceuticals

Hydration Pharmaceuticals Financials at a Glance

HPC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Hydration Pharmaceuticals

HPC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Hydration Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HPC

What is the current price of Hydration Pharmaceuticals?

What is the 52-week range for Hydration Pharmaceuticals?

How much debt does Hydration Pharmaceuticals have?

How much cash does Hydration Pharmaceuticals have on hand?

What is Hydration Pharmaceuticals’s dividend yield?

Premium Investing Services